Intuitive Surgical — Jul 22, 2025 release

“We are committed to advancing care, and helping our customers provide better patient outcomes, better patient and care team experiences, broadening access to care and decreasing the total cost of care.” 2025 Financial Outlook The Company expects the following results for the full year of 2025: • Worldwide da Vinci procedure growth of approximately 15.5% to 17% in 2025, compared to 17% in 2024. • Non-GAAP* gross profit margin to be within a range of 66% and 67% of revenue in 2025, compared to 69.1% in 2024. This range includes an estimated impact from tariffs of 1.0% of revenue, plus or minus 20 basis points. • Non-GAAP* operating expense growth of 10% to 14% in 2025, compared to 10% in 2024. The updated range for expected non-GAAP* gross profit margin reflects the Company’s estimates of the adverse impact from tariffs that are currently in effect as of the time of this press release and assumes such tariffs remain in place. Should additional tariffs be implemented or existing tariffs be modified, the additional impact on the Company’s financial results in 2025, including the change in expected non-GAAP* gross profit margin, could be material. The ultimate effect of tariffs will depend on various factors, including the proportion of components procured and finished goods manufactured outside of the United States and the amount, scope, nature, and timing of the tariffs. The 2025 financial outlook provided above includes forward-looking, non-GAAP financial measures, which management uses in measuring performance. We do not provide a reconciliation of non-GAAP outlook measures to corresponding GAAP measures on a forward-looking basis, because we are u